QI | Medication | Threshold or indication |
---|---|---|
1 | inhibitors of the renin-angiotensin-aldosterone system (RAAS; ACE-I or ARB or Renin-Inhibitors [RI]), calcium channel blockers, β-blockers or thiazides or a combination of these drugs | Arterial hypertension with BP above target (systolic BP >140 mmHg in multiple or 24 h-measurements or >160 mmHg in single measurement) |
2 | Metformin | Diabetes mellitus type 2 (HbA1c >53 mmol/mol (7%)) |
3 | β-blocker | Chronic heart failure (any stage) |
4 | RAAS-I | Chronic heart failure (any stage) |
5 | Aldosterone antagonist | Chronic heart failure, NYHA-stage III or IV |
6 | Oral anticoagulation | Atrial fibrillation |
7 | Statin | Any cardiovascular disease (coronary heart disease, cerebrovascular disease, peripheral vascular disease) |
8 | Platelet aggregation inhibitor | Any cardiovascular disease |
9 | β-blocker | History of myocardial infarction |